CYPRIUM THERAPEUTICS
Live / Registered — Registered (as of 04 May 2021)
What this means for you
Registered since 04 May 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 04 May 2027, and its filing window is open now).
Record
- Serial number
- 87372166
- Registration number
- 6341812
- Mark type
- Word mark
- Filed
- 15 Mar 2017
- Published for opposition
- 13 Feb 2018
- Registered
- 04 May 2021
- Next maintenance filing
- §8 declaration of use, due by 04 May 2027 (grace period to 04 Nov 2027)
- Attorney of record
- Devon E. White
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of Menkes disease and copper transport and metabolism diseases and disorders; Pharmaceutical preparations for human use for the treatment of diseases and disorders where copper deficiency is present; Pharmaceutical preparations for human use for the treatment of hematological and neurological disorders
Owner
- Cyprium Therapeutics, Inc., New York, NY, US
- Cyprium Therapeutics, Inc., New York, NY, US
- Cyprium Therapeutics, Inc., New York, NY, US
Prosecution history
- 04 May 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 04 May 2021 — REGISTERED-PRINCIPAL REGISTER
- 27 Mar 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Mar 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Mar 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Mar 2021 — USE AMENDMENT FILED
- 15 Mar 2021 — TEAS STATEMENT OF USE RECEIVED
- 21 Oct 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Oct 2020 — SOU EXTENSION 5 GRANTED
- 08 Oct 2020 — SOU EXTENSION 5 FILED
- 08 Oct 2020 — SOU TEAS EXTENSION RECEIVED
- 10 Apr 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Apr 2020 — SOU EXTENSION 4 GRANTED
- 08 Apr 2020 — SOU EXTENSION 4 FILED
- 08 Apr 2020 — SOU TEAS EXTENSION RECEIVED